Clinical trial · Interventional
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
Novel e-Health Intervention for Fear of Progression in Women With Gynecologic Cancer: A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (coming back) are common concerns. This may contribute to concerns related to illness, worries, and uncertainty about the future. Day by Day is adapted from a program called "Conquer Fear" which was shown to benefit patients with early-stage cancer. Day-by-day intervention may help refocus patient thoughts and help patients learn skills to manage anxiety and fears.
Conditions
Conditions (11)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Female Reproductive System Neoplasm | Malignant Female Reproductive System Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Stage III Cervical Cancer AJCC v8 | Malignant Cervical Neoplasm | CURATED_BROADER | 0.78 |
| Stage III Ovarian Cancer AJCC v8 | Malignant Ovarian Neoplasm | CURATED_BROADER | 0.78 |
| Stage III Uterine Corpus Cancer AJCC v8 | Malignant Uterine Corpus Neoplasm | CURATED_BROADER | 0.78 |
| Stage III Vaginal Cancer AJCC v8 | Malignant Vaginal Neoplasm | CURATED_BROADER | 0.78 |
| Stage III Vulvar Cancer AJCC v8 | Malignant Vulvar Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Cervical Cancer AJCC v8 | Malignant Cervical Neoplasm |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Discussion | Procedure | — | UNRESOLVED |
| Informational Intervention | Other | — | UNRESOLVED |
| Media Intervention | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Telephone-Based Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive Care (DBD)
- description
- Patients receive DBD intervention consisting of group and web-based self-study sessions and check-in calls on study. Patients also watch videos and receive handouts to reinforce the group sessions.
- interventionNames
- Procedure: Discussion
- Other: Informational Intervention
- Other: Media Intervention
- Other: Questionnaire Administration
- Behavioral: Telephone-Based Intervention
Primary outcomes (1)
- measure
- Feasibility of recruitment (enrollment rate)
- timeFrame
- Up to 6 weeks
- description
- Defined by attendance, attrition, and skills practice adherence. Website acceptability is based on the System Usability Scale, log-in activity, activity completion rate, and most frequently visited site content.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women with stage III or IV GYN cancer (ovarian, endometrial, cervical, vulvar/vaginal);at least 3 months from initial diagnosis * Age: \>= 18 years * Score \>= 34 on the Fear of Progression Short-Form, indicating dysfunctional levels * Ability to read and understand English * Patients in remission or with progressive disease are eligible Exclusion Criteria: * Enrolled in hospice * Severe depression as assessed by Patient Health Questionnaire (PHQ-9) * Non-English speaking * Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
References
Publications (0)
Data not yet available